The European Commission has recently put forth a proposal to amend the EU pharmaceutical legislation on April 26, 2023 (available at https://health.ec.europa.eu/system/files/2023-04/com_2023_193_1_act_en.pdf). This proposed revision aims to establish a unified market for medicines across all EU member states, thereby promoting greater accessibility to novel and effective drugs while also tackling...
Categoría: Uncategorized
WHO warns of too few new drugs for deadly superbugs
The WHO has called on governments and pharmaceutical companies to invest in research and development of new antibiotics and has also recommended that antibiotics be used more judiciously to prevent the emergence of drug-resistant bacteria.
Results, interventions, and qualitative studies debates at the second HAPPY PATIENT face-to-face meeting
Organized by the consortium partner, Universidad de las Palmas de Gran Canaria, and its Fundación Parque Tecnológico, the meeting highlighted the work done in recent months and designed the strategies for the final section of the project. The afternoon of the first day of the meeting, January 26, 2023, was...
More than 400 European experts
participate in the project HAPPY PATIENT
to optimize the use of antibiotics
• One of the research lines of the HAPPY PATIENT European project is to develop a strategy to improve communication between professionals and patients. • As the celebration of the European Day for the Prudent Use of Antibiotics approaches on November 18, it is worth remembering that the adequacy of...
These are the HAPPY PATIENT tools to fight
antimicrobial resistance with communication
The HAPPY PATIENT European project, The Health Alliance for Prudent Prescription and Yield of Antibiotics from a Patient-Centred Perspective, has taken another step forward in its goal of reducing the arbitrary prescription of antibiotics in 4 target countries of the European Union where this type of prescription is higher (Spain, France, Greece and Poland,...
«GPs are playing a much more critical role in nursing homes now than they used to do
before the pandemic»
Ana Moragas is a Family Doctor and a researcher in the field of Infectious Diseases. She is also working closely with HAPPY PATIENT as a member of both IDIAPJGol and semFYC. We had the chance to interview her before her presentation at the 42nd Spanish Conference which was held in...
The debate on deprescription is intensifying in the Nordic countries, and HAPPY PATIENT is the instigator
The HAPPY PATIENT project was presented in the 22nd Nordic Conference of General Practice which took place in Stavanger, Norway, from the 21 to 23 of June 2022. The HAPPY PATIENT symposium was in the biggest room of the congress venue (Mastrafjorden A) and during the one an a half...
WHO IS WHO – NORCE Norwegian Research Centre AS
HAPPY PATIENT targets both patients, primary health care professionals (general practitioners, nurses, dentists and pharmacists), health care professionals working at OOH services, and nursing homes. We will invite the scientific committees and the relevant societies for all the professionals involved (family doctors, nurses, dentists, pharmacists, OOH services, and nursing homes),...
The costs of the Antimicrobial Resistance and the benefits of reducing it
Antimicrobial resistance (AMR) causes harm in the short and long term, to the person suffering from the resistant infection and to the community in which he or she lives, even to the entire planet. They impose costs on patients with susceptible infections, on those who may need antibiotics as prophylaxis,...
AMR: An ever-growing problem
The problem of antimicrobial resistance (AMR) is ever-growing and resolving it is high on the agenda of many international organizations, including the European Commission. They have adopted an action plan against AMR of which the main goals are to make the EU a best practice region and to boost research,...